The Japanese government will enhance its financial support to reform the troubled domestic generic industry in the next five years through a national fund to support the stable supply of such drugs.
After spending years on discussions to address the lingering supply crisis in the sector, the country has decided to try and address “small volume, high mix production” practices within the...